Predictors of survival in systemic sclerosis (Scleroderma)

Wiley - Tập 34 Số 4 - Trang 403-413 - 1991
Roy D. Altman1, Thomas A. Medsger2, D. Blöch3, Beat A. Michel4
1Department of Medicine, University of Miami, School of Medicine, FL 33101.
2Professor of Medicine and Chief, Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
3Senior Research Associate, Divisions of Rheumatology and Biostatistics, Stanford University School of Medicine, Stanford, California
4Fellow in Rheumatology, Stanford University School of Medicine, Stanford, California

Tóm tắt

AbstractWe conducted followup of 264 patients with definite systemic sclerosis (SSc) who were entered into the multicenter Scleroderma Criteria Cooperative Study (SCCS) during 1973–1977. At the end of the study (average 5.2 years of followup), 38% were known to be alive, 50% were dead (68% of these deaths definitely related to SSc), and 12% were lost to followup. Survival analyses of 484 demographic, clinical, and laboratory items recorded at entry into the SCCS (within 2 years of physician diagnosis of SSc) were performed. Survival declined linearly, and the cumulative survival rate was <80% at 2 years, 50% at 8.5 years, and 30% at 12 years after entry. Analysis using combinations of entry variables identifying organ system involvement confirmed that renal, cardiac, pulmonary, and gastrointestinal involvement in SSc predicted reduced survival; however, data on organ system involvement at study entry could not be used to consistently predict which organ system would ultimately be involved as the primary cause of death. By survival tree analysis, the individual entry variables best predicting reduced survival included older age (>64 years), reduced renal function (blood urea nitrogen >16 mg/dl), anemia (hemoglobin ≤11 gm/dl), reduced pulmonary diffusing capacity for carbon monoxide (≤50% of predicted), reduced total serum protein level (≤6 gm/dl), and reduced pulmonary reserve (forced vital capacity <80% with hemoglobin >14 gm/dl or forced vital capacity <65% with hemoglobin ≤14 gm/dl). Cox proportional hazards model analysis confirmed these results. Different combinations of variables led to markedly different survival rates. The poorest prospects for survival were in patients with SSc who were ≤64 years old with a hemoglobin level ≤11 gm/dl, and in those >64 years old with a blood urea nitrogen level >16 mg/dl. These results may be useful in predicting individual patients at risk for shortened survival.

Từ khóa


Tài liệu tham khảo

Medsger TA, 1989, Systemic sclerosis (scleroderma), eosin‐ophilic fasciitis, and calcinosis, Arthritis and Allied Conditions

Seibold JR, 1989, Scleroderma, Textbook of Rheumatology

10.1016/0049-0172(86)90040-5

10.1016/0049-0172(88)90030-3

10.1161/01.CIR.21.6.1088

10.1001/archderm.1961.01580150005001

Medsger TA, 1985, Epidemiology of progressive systemic sclerosis, Current Topics in Rheumatology: Systemic Sclerosis (scleroderma)

10.7326/0003-4819-66-5-870

10.1136/ard.30.6.581

10.7326/0003-4819-75-3-369

10.7326/0003-4819-74-5-714

10.1016/0021-9681(73)90054-4

10.1016/0021-9681(78)90092-9

Neuberger JS, 1984, Epidemiology of the rheumatic diseases, Nurs Clin North Am, 19, 713, 10.1016/S0029-6465(22)01858-8

10.1016/0002-8703(85)90525-3

10.1002/art.1780230510

Masi AT, 1979, Methods and preliminary criteria for the classification of systemic sclerosis (scleroderma), Clin Rheum Dis, 5, 27

10.1002/art.1780230602

10.1002/art.1780310207

10.2307/2531894

10.1002/sim.4780080503

Dixon WJ, 1983, BMDP Statistical Software, revised printing

10.1016/0002-9343(84)90183-9

10.1111/j.1365-2133.1976.tb15535.x

10.1093/rheumatology/27.4.286

10.1002/art.1780260101

10.1016/0002-9343(88)90305-1

Barnett AJ, 1988, A survival study of patients with scleroderma diagnosed over 30 years (1953–1983): the value of a simple cutaneous classification in the early stages of the disease, J Rheumatol, 15, 276

10.7326/0003-4819-57-2-198

Thông tin
Thông tin xuất bản

Wiley

Tập 34 Số 4

403-413

Thông tin tác giả